# Finnish Medicines Agency (Fimea)

Source: https://onco.cc/institutions/fimea-finland/  
OnCo record `fimea-finland` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Finland's medicines regulator, a central agency under the Ministry of Social Affairs and Health. Medicines with a new active substance for cancer must go through the European Medicines Agency's centralised procedure, in which Fimea's pages describe Finland acting as a rapporteur.

## Summary

The Finnish Medicines Agency Fimea describes itself as the national competent authority for regulating pharmaceuticals, a central administrative agency operating under the Ministry of Social Affairs and Health that regulates medicinal products, medical devices, blood and tissue products and biobanks, and develops the pharmaceuticals sector. Its pages describe Finland acting as rapporteur in the EU centralised marketing authorisation procedure and as reference member state in the mutual recognition procedure. The European Medicines Agency states that the centralised procedure is compulsory for medicines with a new active substance to treat cancer. The coordinates are an approximate Helsinki city point.

## Fields

- Kind: Institution
- Last checked: 2026-11-11
- Also known as: Fimea; Lääkealan turvallisuus- ja kehittämiskeskus
- City: Helsinki, FI
- Type: government
- Website: https://fimea.fi/en

## Sources

- Fimea: about us (Internet Archive copy, 15 February 2025): https://web.archive.org/web/20250215204011/https://fimea.fi/en/about_us
- European Medicines Agency: authorisation of medicines, the centralised procedure: https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines

## Connected records

- institutions: [European Medicines Agency](https://onco.cc/institutions/ema/), [Kela, the Social Insurance Institution of Finland](https://onco.cc/institutions/kela-finland/)

---
JSON: https://onco.cc/api/v1/entities/fimea-finland.json